Register now!
  • Boston Scientific joins Avicenna Alliance

    As further evidence of the Alliance’s growing momentum, Avicenna Alliance is happy to announce the newest addition to its list of members: Boston Scientific.

     

    Find out more

  • Avicenna Alliance’s Secretary General to speak at Materialise World Summit 2017

    On the 20 and 21 April 2017 the Materialise World Summit (MWS) will take place, a two-day event which brings together stakeholders from various businesses and industries.

     

    Find out more

  • Avicenna Alliance –Review 2016

    A look back at the year 2016 reveals that it has been a very successful first year for the Avicenna Alliance.

    FIND OUT MORE

FDA confirms its investment in modeling and simulation for improving drug development

Scott Gottlieb commissioner of the USA Food & Drug Administration has recently written an article for the FDA...

find out more ›

MEP Grossetête to visit NovaDiscovery site

On 7 July 2017 MEP Françoise Grossetête (EPP, France) will visit the new site of Avicenna Member, NovaDiscovery in Lyon...

find out more ›

Boston Scientific joins Avicenna Alliance

As further evidence of the Alliance’s growing momentum, Avicenna Alliance is happy to announce the newest addition to its list of members...

find out more ›

Meetings at US Senate Buildings

In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T. Cochran to discuss the...

find out more ›

BMES conference – Frontiers in Medical Devices

In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T. Cochran to...

find out more ›

Signature of Memorandum of Understanding with FDA !

In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T....

find out more ›

Visit to the FDA

In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T. Cochran to discuss the role of in silico...

find out more ›